Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2009 | 1 |
2015 | 1 |
2016 | 1 |
2019 | 2 |
2020 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Promising Therapeutic Efficacy of GC1118, an Anti-EGFR Antibody, against KRAS Mutation-Driven Colorectal Cancer Patient-Derived Xenografts.
Int J Mol Sci. 2019 Nov 24;20(23):5894. doi: 10.3390/ijms20235894.
Int J Mol Sci. 2019.
PMID: 31771279
Free PMC article.
Therapeutic Efficacy of GC1118, a Novel Anti-EGFR Antibody, against Glioblastoma with High EGFR Amplification in Patient-Derived Xenografts.
Lee K, Koo H, Kim Y, Kim D, Son E, Yang H, Lim Y, Hur M, Lee HW, Choi SW, Nam DH.
Lee K, et al. Among authors: hur m.
Cancers (Basel). 2020 Oct 31;12(11):3210. doi: 10.3390/cancers12113210.
Cancers (Basel). 2020.
PMID: 33142709
Free PMC article.
Item in Clipboard
GC1118, a novel anti-EGFR antibody, has potent KRAS mutation-independent antitumor activity compared with cetuximab in gastric cancer.
Park JE, Jin MH, Hur M, Nam AR, Bang JH, Won J, Oh DY, Bang YJ.
Park JE, et al. Among authors: hur m.
Gastric Cancer. 2019 Sep;22(5):932-940. doi: 10.1007/s10120-019-00943-x. Epub 2019 Feb 27.
Gastric Cancer. 2019.
PMID: 30815759
Item in Clipboard
GC1118, an Anti-EGFR Antibody with a Distinct Binding Epitope and Superior Inhibitory Activity against High-Affinity EGFR Ligands.
Lim Y, Yoo J, Kim MS, Hur M, Lee EH, Hur HS, Lee JC, Lee SN, Park TW, Lee K, Chang KH, Kim K, Kang Y, Hong KW, Kim SH, Kim YG, Yoon Y, Nam DH, Yang H, Kim DG, Cho HS, Won J.
Lim Y, et al. Among authors: hur m.
Mol Cancer Ther. 2016 Feb;15(2):251-63. doi: 10.1158/1535-7163.MCT-15-0679. Epub 2015 Nov 19.
Mol Cancer Ther. 2016.
PMID: 26586721
Item in Clipboard
Oral administration of 1,4-aryl-2-mercaptoimidazole inhibits T-cell proliferation and reduces clinical severity in the murine experimental autoimmune encephalomyelitis model.
Jung EJ, Hur M, Kim YL, Lee GH, Kim J, Kim I, Lee M, Han HK, Kim MS, Hwang S, Kim S, Woo AM, Yoon Y, Park HJ, Won J.
Jung EJ, et al. Among authors: hur m.
J Pharmacol Exp Ther. 2009 Dec;331(3):1005-13. doi: 10.1124/jpet.109.154948. Epub 2009 Sep 9.
J Pharmacol Exp Ther. 2009.
PMID: 19741152
Item in Clipboard
Cite
Cite